Ketamine Versus Propofol Effect on the Immune-mediatory Response for Abdominal Surgery
Immune-mediatory Response of Intravenous Ketamine Versus Propofol for Major Abdominal Surgeries: a Prospective Randomized Study
1 other identifier
interventional
36
0 countries
N/A
Brief Summary
Host systemic responses to vigorous stimuli as trauma, surgical tissue injury, anesthesia and post-operative pain, leads to release a variety of pro-inflammatory cytokines including interleukin-1 (IL-1) and interleukin-6 (IL-6) mainly from monocytes and macrophages Thus, the rise of IL-6 is regarded as an early marker of tissue damage and its rise proportional to the degree of tissue damage . It has been demonstrated that systemic responses to stress may be modified by the anesthetic technique used . Total intravenous anesthesia (TIVA) especially propofol based greatly suppresses the stress response induced by surgery when compared to inhalation by lowering cortisol levels. Ketamine has the ability to modulate (modify) inflammation . Even the sub-anesthetic doses of ketamine in animal models were even provided to have an effect on the inflammatory response system in the central nervous system
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2018
CompletedFirst Posted
Study publicly available on registry
January 4, 2019
CompletedStudy Start
First participant enrolled
January 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2019
CompletedJanuary 7, 2019
January 1, 2019
5 months
December 30, 2018
January 3, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Serum level of interleukin 6 (IL-6)
picogram/milliliter using ELISA techniques .Five measurement points : before the induction of general anesthesia, 30 min after beginning infusion of the anesthetic agent , then 2h, 8h and 24 hours postoperative.
The time frame extend from 10 minutes before the induction of anesthesia till the first 24 hours postoperative
Serum level of interleukin IL-1β (IL-1β)
picogram/milliliter using ELSA techniques .Five measurement points : before the induction of general anesthesia, 30 min after beginning infusion of the anesthetic agent , then 2h, 8h and 24 hours postoperative.
The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative
Secondary Outcomes (5)
Absolute neutrophil count
The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative
Total leukocyte count
The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative
Neutrophil-lymphocyte ratio (N/L ratio)
The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative
Serum Cortisol level
The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative
C-reactive protein serum level
The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative
Study Arms (2)
Propofol group (P)
PLACEBO COMPARATORThe maintenance of anesthesia , patient will receive sevoflurane 1%-2.5% with intravenous infusion of propofol 17 mcg /kg/min and 0.5 mg/kg fentanyl will be given if the heart rate or mean blood pressure increased by 30 % or more from the basal readings
Ketamine group ((K)
ACTIVE COMPARATORThe maintenance of anesthesia , patient will receive sevoflurane 1%-2.5% with intravenous infusion of ketamine 5 mcg /kg/min and 0.5 mg/kg fentanyl will be given if the heart rate or mean blood pressure increased by 30 % or more from the basal readings
Interventions
Eligibility Criteria
You may qualify if:
- Elective major abdominal surgeries with median incision with right or left extension.
- ASA -physical status I -II
- aged from 18 till 70 years
You may not qualify if:
- body mass index more than 35 kg/m2,
- Patients having severe cardiovascular, respiratory, hepatic, renal, Endocrinol disorders, malignant
- Patients having chronic inflammatory diseases
- Patients received suppressant drugs in the 6 weeks before surgery.
- Any known allergy or any contraindications to anesthetic drugs;
- patient refusal,
- The usage of anti- emetic drug 24 hours before operation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Reem Abdelraouf, lecturer
Mansoura University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- Double -blinded ( masking of both participant and care provider)
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of anesthesia and surgical intensive care
Study Record Dates
First Submitted
December 30, 2018
First Posted
January 4, 2019
Study Start
January 10, 2019
Primary Completion
June 1, 2019
Study Completion
August 15, 2019
Last Updated
January 7, 2019
Record last verified: 2019-01